In vitro model for evaluating drug transport across the blood-brain barrier.
about
3D in vitro modeling of the central nervous systemConstructive remodeling of a synthetic endothelial extracellular matrix.Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative DiseasesPharmacological characterization of designer cathinones in vitroA simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrierInstruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypesA zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluationComparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaPericytes from Mesenchymal Stem Cells as a model for the blood-brain barrier.Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β)How to measure drug transport across the blood-brain barrierMultifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cellsBrainpeps: the blood-brain barrier peptide database.Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studiesSetting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transportA new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.Transcytosis: crossing cellular barriers.Monocytes form a vascular barrier and participate in vessel repair after brain injury.Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood-Brain BarrierBrain pericytes from stress-susceptible pigs increase blood-brain barrier permeability in vitroReceptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors.ATP-binding cassette transporters in immortalised human brain microvascular endothelial cells in normal and hypoxic conditionsModeling the blood-brain barrier using stem cell sources.Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistanceMultifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.Light-controlled inhibition of malignant glioma by opsin gene transfer.Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model.The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.Integrating in vitro organ-specific function with the microcirculation.Blood-brain barrier structure and function and the challenges for CNS drug delivery.Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.The blood-brain barrier: an engineering perspective.Overview of experimental models of the blood-brain barrier in CNS drug discovery.
P2860
Q27026457-0F253461-636C-426D-B558-071C516566A4Q27303687-4118AFFD-1E54-454A-9A5E-57A2E27A910DQ28071254-180996CF-2CE5-4B5C-8F7C-3A317BAA0C7FQ28273207-12E61E04-0005-4E6D-A0FE-34AAEE322E08Q28535720-AB5628E0-77FA-4366-AC14-F8B5A2DCEC90Q28538281-A0DE7E48-E149-4AA1-B4CD-03B07FF2D22CQ30487256-E6F67BA0-345A-49A3-8228-EEAEDFE62D18Q30498346-CE576F1C-9C65-4E12-A358-60818276CF8AQ30499386-6861080B-B76E-4E45-B8FC-0F32202EC302Q30577878-AAFF9CC6-D4AF-4F48-BCAD-23B949BAFFFAQ30835318-5C7E436E-CB98-4FC1-9C48-761ED68CEA18Q30837035-5C09A14C-8E82-48C4-B5E3-F72962F7CC54Q33664977-7D38D2E4-24C3-40E2-9919-6E746C8337D6Q33985116-7D3BC628-6835-48A0-9D96-417E2018266FQ34227784-0650F719-4C57-4298-AA19-BF1AE689615AQ34243408-8E7576B5-7AA0-4437-AC53-B702E4D4A72AQ34250155-18D579CB-2905-4419-895A-686A4F5B54DAQ34400993-3D4622EF-6521-4FB3-B7F7-4BA0D97925B9Q35105995-07783FF7-8A35-48CC-9BFD-21AB419758CBQ35169907-3B92FEFE-6FDC-49FE-A5DD-7BCF6623B4E9Q35849990-B2BFF5D5-60C7-4AC7-8C0F-B2E6AD0F535BQ35952488-6441CB9A-1285-4DC9-A6EE-D58B741A4306Q36068514-FEAEEFB1-5489-424B-ACF0-42A966783678Q36143895-2D4DA266-A470-46EC-A036-3CC152700E94Q36303213-3BAF71A3-0FDE-4168-8FA4-89200D9AD39FQ36588683-19BCAF78-7475-4F01-B1F5-8E18867F540DQ36783549-BC86300D-A1D3-466D-ADD4-355B1F7E4F36Q36839343-222EB647-DE5C-4362-8F1A-5103B27B48A6Q36959343-3BB38090-4126-477A-86D1-349B5993EC65Q37269377-C778967C-F8A7-40A5-B807-4F0F1DA4C93AQ37296720-1B7FF5A0-F77D-48F7-AF9A-121D96930A1DQ37413195-C370435C-28C7-4825-A41D-3448D94550BAQ37577428-BFDBF51C-9460-4AC2-BE57-A150D07F4869Q37651320-68FF44EE-3287-4572-8359-9CE160F206F1Q37664869-D4884EE3-4226-4D92-8D88-0B234C7E9F5FQ37691970-536A52B4-54C0-4CE9-8EFA-13F119A1F420Q38100970-858BD454-6852-4A14-B588-409C955A95CFQ38117056-68D75CA3-EFF4-4757-8A55-90D97A702CD2Q38134725-8C73F18E-F32A-410C-ADD7-0B324647AEF8Q38186650-BD6B7645-768F-4759-A5A6-0567F6BD6388
P2860
In vitro model for evaluating drug transport across the blood-brain barrier.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In vitro model for evaluating drug transport across the blood-brain barrier.
@ast
In vitro model for evaluating drug transport across the blood-brain barrier.
@en
type
label
In vitro model for evaluating drug transport across the blood-brain barrier.
@ast
In vitro model for evaluating drug transport across the blood-brain barrier.
@en
prefLabel
In vitro model for evaluating drug transport across the blood-brain barrier.
@ast
In vitro model for evaluating drug transport across the blood-brain barrier.
@en
P2093
P1476
In vitro model for evaluating drug transport across the blood-brain barrier.
@en
P2093
Buée-Scherrer V V
Cecchelli R
Dehouck MP
Descamps L
Lundquist S
P304
P356
10.1016/S0169-409X(98)00083-0
P407
P577
1999-04-01T00:00:00Z